Morgan Stanley »

Crinetics Pharmaceuticals In shares owned by Morgan Stanley

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $38M 839k 44.79
2024-03-31 $29M 612k 46.81
2023-12-31 $23M 648k 35.58
2023-09-30 $15M 511k 29.74
2023-06-30 $13M 746k 18.02
2022-12-31 $2.8M 153k 18.30
2022-06-30 $2.4M 140k 17.24
2022-03-31 $2.1M 95k 21.95
2021-06-30 $3.4M 182k 18.87
2020-12-31 $2.6M 186k 14.09
2020-09-30 $642k 41k 15.77
2020-06-30 $3.7M 214k 17.51
2020-03-31 $34k 2.3k 15.22
2019-12-31 $437k 17k 25.11
2019-09-30 $266k 18k 15.14
2019-03-31 $67k 3.0k 22.52
2018-12-31 $366k 12k 30.00
2018-09-30 $353k 12k 28.65